nach oben

Metabolic Brain Disease

Erschienen in:

17.03.2020 | Review Article

Molecular mechanisms underlying actions of certain long noncoding RNAs in Alzheimer’s disease

verfasst von: Shamseddin Ahmadi, Mohammad Zobeiri, Steven Bradburn

Erschienen in: Metabolic Brain Disease | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Long non-coding RNAs (lncRNAs) are a group of non-protein coding RNAs that have more than 200 nucleotides. LncRNAs play an important role in the regulation of protein-coding genes at the transcriptional and post-transcriptional levels. They are found in most organs, with a high prevalence in the central nervous system. Accumulating data suggests that lncRNAs are involved in various neurodegenerative disorders, including the onset and progression of Alzheimer’s disease (AD). Recent insights suggest lncRNAs, such as BACE1-AS, 51A, 17A, NDM29 and AS-UCHL1, are dysregulated in AD tissues. Furthermore, there are ongoing efforts to explore the clinical usability of lncRNAs as biomarkers in the disease. In this review, we explore the mechanisms by which aberrant expressions of the most studied lncRNAs contribute to the neuropathologies associated with AD, including amyloid β plaques and neurofibrillary tangles. Understanding the molecular mechanisms of lncRNAs in patients with AD will reveal novel diagnosis strategies and more effective therapeutic targets.

Adams SJ, Crook RJ, Deture M, Randle SJ, Innes AE, Yu XZ, Lin WL, Dugger BN, McBride M, Hutton M, Dickson DW, McGowan E (2009) Overexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration. Am J Pathol 175:1598–1609PubMedPubMedCentralCrossRef

Airavaara M, Pletnikova O, Doyle ME, Zhang YE, Troncoso JC, Liu QR (2011) Identification of novel GDNF isoforms and cis-antisense GDNFOS gene and their regulation in human middle temporal gyrus of Alzheimer disease. J Biol Chem 286:45093–45102PubMedPubMedCentralCrossRef

Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK (2013) GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther 138:155–175PubMedCrossRef

Alonso AD, Zaidi T, Novak M, Barra HS, Grundke-Iqbal I, Iqbal K (2001) Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein. J Biol Chem 276:37967–37973PubMedCrossRef

Amlie-Wolf A et al. (2019) Inferring the molecular mechanisms of noncoding Alzheimer's disease-associated genetic variants. J Alzheimers Dis

Ayupe AC, Tahira AC, Camargo L, Beckedorff FC, Verjovski-Almeida S, Reis EM (2015) Global analysis of biogenesis, stability and sub-cellular localization of lncRNAs mapping to intragenic regions of the human genome. RNA Biol 12:877–892PubMedPubMedCentralCrossRef

Balietti M, Giuli C, Conti F (2018) Peripheral blood brain-derived Neurotrophic factor as a biomarker of Alzheimer's disease: are there methodological biases? Mol Neurobiol 55:6661–6672PubMedPubMedCentralCrossRef

Barbero-Camps E, Roca-Agujetas V, Bartolessis I, de Dios C, Fernández-Checa JC, Marí M, Morales A, Hartmann T, Colell A (2018) Cholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion. Autophagy 14:1129–1154PubMedPubMedCentralCrossRef

Basile V, Vicente A, Martignetti JA, Skryabin BV, Brosius J, Kennedy JL (1998) Assignment of the human BC200 RNA gene (BCYRN1) to chromosome 2p16 by radiation hybrid mapping. Cytogenet Cell Genet 82:271–272PubMedCrossRef

Berson A, Nativio R, Berger SL, Bonini NM (2018) Epigenetic regulation in neurodegenerative diseases. Trends Neurosci 41:587–598PubMedPubMedCentralCrossRef

Bloom GS (2014) Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71:505–508PubMedCrossRef

Bradley LH et al (2010) Dopamine neuron stimulating actions of a GDNF propeptide. PLoS One 5:e9752PubMedPubMedCentralCrossRef

Buggia-Prevot V, Thinakaran G (2014) Sorting the role of SORLA in Alzheimer's disease. Sci Transl med 6:223fs228CrossRef

Caglayan S et al (2014) Lysosomal sorting of amyloid-beta by the SORLA receptor is impaired by a familial Alzheimer's disease mutation. Sci Transl med 6:223ra220CrossRef

Caillet-Boudin ML, Buee L, Sergeant N, Lefebvre B (2015) Regulation of human MAPT gene expression. Mol Neurodegener 10:28PubMedPubMedCentralCrossRef

Canugovi C, Misiak M, Ferrarelli LK, Croteau DL, Bohr VA (2013) The role of DNA repair in brain related disease pathology. DNA Repair (Amst) 12:578–587CrossRef

Carrieri C, Cimatti L, Biagioli M, Beugnet A, Zucchelli S, Fedele S, Pesce E, Ferrer I, Collavin L, Santoro C, Forrest AR, Carninci P, Biffo S, Stupka E, Gustincich S (2012) Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature 491:454–457PubMedCrossRef

Castelnuovo M, Massone S, Tasso R, Fiorino G, Gatti M, Robello M, Gatta E, Berger A, Strub K, Florio T, Dieci G, Cancedda R, Pagano A (2010) An Alu-like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells. FASEB J 24:4033–4046PubMedCrossRef

Chen M (2015) The maze of APP processing in Alzheimer's disease: where did we go wrong in reasoning? Front Cell Neurosci 9:186PubMedPubMedCentral

Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin LS, Li L (2004) Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem 279:13256–13264PubMedCrossRef

Ciarlo E, Massone S, Penna I, Nizzari M, Gigoni A, Dieci G, Russo C, Florio T, Cancedda R, Pagano A (2013) An intronic ncRNA-dependent regulation of SORL1 expression affecting Abeta formation is upregulated in post-mortem Alzheimer's disease brain samples. Dis Model Mech 6:424–433PubMed

Clark MB, Johnston RL, Inostroza-Ponta M, Fox AH, Fortini E, Moscato P, Dinger ME, Mattick JS (2012) Genome-wide analysis of long noncoding RNA stability. Genome Res 22:885–898PubMedPubMedCentralCrossRef

Consortium TEP et al (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489:57CrossRef

Coupland KG, Kim WS, Halliday GM, Hallupp M, Dobson-Stone C, Kwok JB (2016) Role of the Long non-coding RNA MAPT-AS1 in regulation of microtubule associated protein tau (MAPT) expression in Parkinson's disease. PLoS One 11:e0157924PubMedPubMedCentralCrossRef

de Almeida RA, Fraczek MG, Parker S, Delneri D, O'Keefe RT (2016) Non-coding RNAs and disease: the classical ncRNAs make a comeback. Biochem Soc Trans 44:1073–1078PubMedPubMedCentralCrossRef

de Rie D, Abugessaisa I, Alam T, Arner E, Arner P, Ashoor H, Åström G, Babina M, Bertin N, Burroughs AM, Carlisle AJ, Daub CO, Detmar M, Deviatiiarov R, Fort A, Gebhard C, Goldowitz D, Guhl S, Ha TJ, Harshbarger J, Hasegawa A, Hashimoto K, Herlyn M, Heutink P, Hitchens KJ, Hon CC, Huang E, Ishizu Y, Kai C, Kasukawa T, Klinken P, Lassmann T, Lecellier CH, Lee W, Lizio M, Makeev V, Mathelier A, Medvedeva YA, Mejhert N, Mungall CJ, Noma S, Ohshima M, Okada-Hatakeyama M, Persson H, Rizzu P, Roudnicky F, Sætrom P, Sato H, Severin J, Shin JW, Swoboda RK, Tarui H, Toyoda H, Vitting-Seerup K, Winteringham L, Yamaguchi Y, Yasuzawa K, Yoneda M, Yumoto N, Zabierowski S, Zhang PG, Wells CA, Summers KM, Kawaji H, Sandelin A, Rehli M, FANTOM Consortium, Hayashizaki Y, Carninci P, Forrest ARR, de Hoon MJL (2017) An integrated expression atlas of miRNAs and their promoters in human and mouse. Nat Biotechnol 35:872–878PubMedPubMedCentralCrossRef

Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG, Lagarde J, Veeravalli L, Ruan X, Ruan Y, Lassmann T, Carninci P, Brown JB, Lipovich L, Gonzalez JM, Thomas M, Davis CA, Shiekhattar R, Gingeras TR, Hubbard TJ, Notredame C, Harrow J, Guigó R (2012) The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 22:1775–1789PubMedPubMedCentralCrossRef

Diederichs S (2014) The four dimensions of noncoding RNA conservation. Trends Genet 30:121–123PubMedCrossRef

Du Toit A (2013) Non-coding RNA: RNA stability control by pol II. Nat Rev Mol Cell Biol 14:128PubMedCrossRef

Ebbesen KK, Hansen TB, Kjems J (2017) Insights into circular RNA biology. RNA Biol 14:1035–1045PubMedCrossRef

Ecker JR, Bickmore WA, Barroso I, Pritchard JK, Gilad Y, Segal E (2012) ENCODE explained. Nature 489:52–54CrossRefPubMed

Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE, Finch CE, St Laurent G 3rd, Kenny PJ, Wahlestedt C (2008) Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 14:723–730PubMedPubMedCentralCrossRef

Faghihi MA et al (2010) Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol 11:R56PubMedPubMedCentralCrossRef

Faria MC, Gonçalves GS, Rocha NP, Moraes EN, Bicalho MA, Gualberto Cintra MT, Jardim de Paula J, José Ravic de Miranda LF, Clayton de Souza Ferreira A, Teixeira AL, Gomes KB, Carvalho Md, Sousa LP (2014) Increased plasma levels of BDNF and inflammatory markers in Alzheimer's disease. J Psychiatr Res 53:166–172PubMedCrossRef

Feng L et al (2018) Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease. BMC Neurol 18:4PubMedPubMedCentralCrossRef

Forlenza OV, Miranda AS, Guimar I, Talib LL, Diniz BS, Gattaz WF, Teixeira AL (2015) Decreased Neurotrophic support is associated with cognitive decline in non-demented subjects. J Alzheimers Dis 46:423–429PubMedCrossRef

Fotuhi SN, Khalaj-Kondori M, Hoseinpour Feizi MA, Talebi M (2019) Long non-coding RNA BACE1-AS may serve as an Alzheimer’s disease blood-based biomarker. J Mol Neurosci

Gavazzo P, Vassalli M, Costa D, Pagano A (2013) Novel ncRNAs transcribed by pol III and elucidation of their functional relevance by biophysical approaches. Front Cell Neurosci 7:203PubMedPubMedCentralCrossRef

Geisler S, Coller J (2013) RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol 14:699–712PubMedPubMedCentralCrossRef

Goedert M, Jakes R, Spillantini MG, Hasegawa M, Smith MJ, Crowther RA (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383:550–553PubMedCrossRef

Gouras GK, Willen K, Faideau M (2014) The inside-out amyloid hypothesis and synapse pathology in Alzheimer's disease. Neurodegener Dis 13:142–146PubMedCrossRef

Grimm L, Holinski-Feder E, Teodoridis J, Scheffer B, Schindelhauer D, Meitinger T, Ueffing M (1998) Analysis of the human GDNF gene reveals an inducible promoter, three exons, a triplet repeat within the 3'-UTR and alternative splice products. Hum Mol Genet 7:1873–1886PubMedCrossRef

Gu C, Chen C, Wu R, Dong T, Hu X, Yao Y, Zhang Y (2018) Long noncoding RNA EBF3-AS promotes neuron apoptosis in Alzheimer's disease. DNA Cell Biol 37:220–226PubMedCrossRef

Guenzl PM, Barlow DP (2012) Macro lncRNAs: a new layer of cis-regulatory information in the mammalian genome. RNA Biol 9:731–741PubMedCrossRef

Gui Y, Liu H, Zhang L, Lv W, Hu X (2015) Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget 6:37043–37053PubMedPubMedCentralCrossRef

Guo CC, Jiao CH, Gao ZM (2018) Silencing of LncRNA BDNF-AS attenuates Abeta25-35-induced neurotoxicity in PC12 cells by suppressing cell apoptosis and oxidative stress. Neurol Res 40:795–804PubMedCrossRef

Herskowitz JH, Offe K, Deshpande A, Kahn RA, Levey AI, Lah JJ (2012) GGA1-mediated endocytic traffic of LR11/SorLA alters APP intracellular distribution and amyloid-beta production. Mol Biol Cell 23:2645–2657PubMedPubMedCentralCrossRef

Holstege H, van der Lee S, Hulsman M, Wong TH, van Rooij J, Weiss M, Louwersheimer E, Wolters FJ, Amin N, Uitterlinden AG, Hofman A, Ikram MA, van Swieten J, Meijers-Heijboer H, van der Flier W, Reinders MJ, van Duijn C, Scheltens P (2017) Characterization of pathogenic SORL1 genetic variants for association with Alzheimer's disease: a clinical interpretation strategy. Eur J Hum Genet 25:973–981PubMedPubMedCentralCrossRef

Hombach S, Kretz M (2016) Non-coding RNAs: classification, biology and functioning. Adv Exp Med Biol 937:3–17PubMedCrossRef

Hon C-C et al (2017) An atlas of human long non-coding RNAs with accurate 5′ ends. Nature 543:199PubMedPubMedCentralCrossRef

Hong L, Huang HC, Jiang ZF (2014) Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease. Neurol Res 36:276–282PubMedCrossRef

Hou Y, Song H, Croteau DL, Akbari M, Bohr VA (2017) Genome instability in Alzheimer disease. Mech Ageing Dev 161:83–94PubMedCrossRef

Hu W, Wen L, Cao F, Wang Y (2019) Down-regulation of Mir-107 worsen spatial memory by suppressing SYK expression and inactivating NF-KappaB signaling pathway. Curr Alzheimer Res 16:135–145PubMedCrossRef

Jacobsen L, Madsen P, Nielsen MS, Geraerts WP, Gliemann J, Smit AB, Petersen CM (2002) The sorLA cytoplasmic domain interacts with GGA1 and −2 and defines minimum requirements for GGA binding. FEBS Lett 511:155–158PubMedCrossRef

Jahn H (2013) Memory loss in Alzheimer's disease. Dialogues Clin Neurosci 15:445–454PubMedPubMedCentralCrossRef

Jia H, Osak M, Bogu GK, Stanton LW, Johnson R, Lipovich L (2010) Genome-wide computational identification and manual annotation of human long noncoding RNA genes. Rna 16:1478–1487PubMedPubMedCentralCrossRef

Jiang Q, Shan K, Qun-Wang X, Zhou RM, Yang H, Liu C, Li YJ, Yao J, Li XM, Shen Y, Cheng H, Yuan J, Zhang YY, Yan B (2016) Long non-coding RNA-MIAT promotes neurovascular remodeling in the eye and brain. Oncotarget 7:49688–49698PubMedPubMedCentralCrossRef

Johnsson P, Lipovich L, Grander D, Morris KV (2014) Evolutionary conservation of long non-coding RNAs; sequence, structure, function. Biochim Biophys Acta 1840:1063–1071PubMedCrossRef

Joubert S, Gour N, Guedj E, Didic M, Guériot C, Koric L, Ranjeva JP, Felician O, Guye M, Ceccaldi M (2016) Early-onset and late-onset Alzheimer's disease are associated with distinct patterns of memory impairment. Cortex 74:217–232PubMedCrossRef

Kashi K, Henderson L, Bonetti A, Carninci P (2016) Discovery and functional analysis of lncRNAs: methodologies to investigate an uncharacterized transcriptome. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1859:3–15CrossRef

Ke S, Yang Z, Yang F, Wang X, Tan J, Liao B (2019) Long noncoding RNA NEAT1 aggravates Abeta-induced neuronal damage by targeting miR-107 in Alzheimer's disease. Yonsei Med J 60:640–650PubMedPubMedCentralCrossRef

Kellner Y, Godecke N, Dierkes T, Thieme N, Zagrebelsky M, Korte M (2014) The BDNF effects on dendritic spines of mature hippocampal neurons depend on neuronal activity. Front Synaptic Neurosci 6:5PubMedPubMedCentralCrossRef

Khaledi S, Ahmadi S (2016) Amyloid Beta and tau: from physiology to pathology in Alzheimer’s disease. Shefaye Khatam 4:67–88

Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT (2018) Inflammation as a central mechanism in Alzheimer's disease. Alzheimer's & dementia (New York, N Y) 4:575–590CrossRef

Kornienko AE, Guenzl PM, Barlow DP, Pauler FM (2013) Gene regulation by the act of long non-coding RNA transcription. BMC Biol 11:59PubMedPubMedCentralCrossRef

Lai F, Orom UA, Cesaroni M, Beringer M, Taatjes DJ, Blobel GA, Shiekhattar R (2013) Activating RNAs associate with mediator to enhance chromatin architecture and transcription. Nature 494:497–501PubMedPubMedCentralCrossRef

Lane CA, Hardy J, Schott JM (2018) Alzheimer's disease. Eur J Neurol 25:59–70PubMedCrossRef

Lee JG, Shin BS, You YS, Kim JE, Yoon SW, Jeon DW, Baek JH, Park SW, Kim YH (2009) Decreased serum brain-derived neurotrophic factor levels in elderly korean with dementia. Psychiatry Investig 6:299–305PubMedPubMedCentralCrossRef

Li H, Zheng L, Jiang A, Mo Y, Gong Q (2018) Identification of the biological affection of long noncoding RNA BC200 in Alzheimer’s disease. Neuroreport 29:1061–1067PubMedCrossRef

Liu DY, Zhang L (2019) MicroRNA-132 promotes neurons cell apoptosis and activates tau phosphorylation by targeting GTDC-1 in Alzheimer's disease. Eur Rev Med Pharmacol Sci 23:8523–8532PubMed

Liu T, Huang Y, Chen J, Chi H, Yu Z, Wang J, Chen C (2014) Attenuated ability of BACE1 to cleave the amyloid precursor protein via silencing long noncoding RNA BACE1AS expression. Mol Med Rep 10:1275–1281PubMedPubMedCentralCrossRef

Liu X, Jiao B, Shen L (2018) The epigenetics of Alzheimer's disease: factors and therapeutic implications. Front Genet 9:579PubMedPubMedCentralCrossRef

Luo Q, Chen Y (2016) Long noncoding RNAs and Alzheimer's disease. Clin Interv Aging 11:867–872PubMedPubMedCentralCrossRef

Ma L, Bajic VB, Zhang Z (2013) On the classification of long non-coding RNAs. RNA Biol 10:925–933PubMed

Magistri M, Velmeshev D, Makhmutova M, Faghihi MA (2015) Transcriptomics profiling of Alzheimer's disease reveal neurovascular defects, altered amyloid-beta homeostasis, and deregulated expression of Long noncoding RNAs. J Alzheimers Dis 48:647–665PubMedPubMedCentralCrossRef

Mao YS, Zhang B, Spector DL (2011) Biogenesis and function of nuclear bodies. Trends Genet 27:295–306PubMedPubMedCentralCrossRef

Maresova P, Mohelska H, Dolejs J, Kuca K (2015) Socio-economic aspects of Alzheimer's disease. Curr Alzheimer Res 12:903–911PubMedCrossRef

Martignetti JA, Brosius J (1993) BC200 RNA: a neural RNA polymerase III product encoded by a monomeric Alu element. Proc Natl Acad Sci U S A 90:11563–11567PubMedPubMedCentralCrossRef

Massone S, Ciarlo E, Vella S, Nizzari M, Florio T, Russo C, Cancedda R, Pagano A (2012) NDM29, a RNA polymerase III-dependent non coding RNA, promotes amyloidogenic processing of APP and amyloid beta secretion. Biochim Biophys Acta 1823:1170–1177PubMedCrossRef

Massone S, Vassallo I, Fiorino G, Castelnuovo M, Barbieri F, Borghi R, Tabaton M, Robello M, Gatta E, Russo C, Florio T, Dieci G, Cancedda R, Pagano A (2011) 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease. Neurobiol Dis 41:308–317PubMedCrossRef

Matsushita N, Fujita Y, Tanaka M, Nagatsu T, Kiuchi K (1997) Cloning and structural organization of the gene encoding the mouse glial cell line-derived neurotrophic factor, GDNF. Gene 203:149–157PubMedCrossRef

Mattick JS, Makunin IV (2006) Non-coding RNA. Hum Mol genet 15 spec no 1:R17-29

McCartney DL, Stevenson AJ, Walker RM, Gibson J, Morris SW, Campbell A, Murray AD, Whalley HC, Porteous DJ, McIntosh A, Evans KL, Deary IJ, Marioni RE (2018) Investigating the relationship between DNA methylation age acceleration and risk factors for Alzheimer's disease. Alzheimers Dement (Amst) 10:429–437CrossRef

McMullen JR, Drew BG (2016) Long non-coding RNAs (lncRNAs) in skeletal and cardiac muscle: potential therapeutic and diagnostic targets? Clin Sci (Lond) 130:2245–2256CrossRef

Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS (2008) Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci U S A 105:716–721PubMedPubMedCentralCrossRef

Millan MJ (2014) The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity? Dialogues Clin Neurosci 16:373–393PubMedPubMedCentralCrossRef

Millan MJ (2017) Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: an integrative review. Prog Neurobiol 156:1–68PubMedCrossRef

Modarresi F, Faghihi MA, Lopez-Toledano MA, Fatemi RP, Magistri M, Brothers SP, van der Brug M, Wahlestedt C (2012) Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat Biotechnol 30:453–459PubMedPubMedCentralCrossRef

Mrak RE, Griffin WS (2001) Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol Aging 22:903–908PubMedCrossRef

Muller UC, Deller T, Korte M (2017) Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci 18:281–298PubMedCrossRef

Mus E, Hof PR, Tiedge H (2007) Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc Natl Acad Sci U S A 104:10679–10684PubMedPubMedCentralCrossRef

Naganuma T, Nakagawa S, Tanigawa A, Sasaki YF, Goshima N, Hirose T (2012) Alternative 3′-end processing of long noncoding RNA initiates construction of nuclear paraspeckles. EMBO J 31:4020–4034PubMedPubMedCentralCrossRef

Necsulea A, Soumillon M, Warnefors M, Liechti A, Daish T, Zeller U, Baker JC, Grützner F, Kaessmann H (2014) The evolution of lncRNA repertoires and expression patterns in tetrapods. Nature 505:635–640PubMedCrossRef

Nelson PT, Wang WX (2010) MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. J Alzheimers Dis 21:75–79PubMedPubMedCentralCrossRef

O'Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci 34:185–204PubMedPubMedCentralCrossRef

Parenti R, Paratore S, Torrisi A, Cavallaro S (2007) A natural antisense transcript against Rad18, specifically expressed in neurons and upregulated during beta-amyloid-induced apoptosis. Eur J Neurosci 26:2444–2457PubMedCrossRef

Peric A, Annaert W (2015) Early etiology of Alzheimer's disease: tipping the balance toward autophagy or endosomal dysfunction? Acta Neuropathol 129:363–381PubMedPubMedCentralCrossRef

Pohanka M (2014) Alzheimer s disease and oxidative stress: a review. Curr Med Chem 21:356–364PubMedCrossRef

Quan M, Chen J, Zhang D (2015) Exploring the secrets of long noncoding RNAs. Int J Mol Sci 16:5467–5496PubMedPubMedCentralCrossRef

Ramos AD et al (2013) Integration of genome-wide approaches identifies lncRNAs of adult neural stem cells and their progeny in vivo. Cell Stem Cell 12:616–628PubMedPubMedCentralCrossRef

Rashid F, Shah A, Shan G (2016) Long non-coding RNAs in the cytoplasm. Genomics Proteomics Bioinformatics 14:73–80PubMedPubMedCentralCrossRef

Riva P, Ratti A, Venturin M (2016) The Long non-coding RNAs in neurodegenerative diseases: novel mechanisms of pathogenesis. Curr Alzheimer Res 13:1219–1231PubMedCrossRef

Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, Katayama T, Baldwin CT, Cheng R, Hasegawa H, Chen F, Shibata N, Lunetta KL, Pardossi-Piquard R, Bohm C, Wakutani Y, Cupples LA, Cuenco KT, Green RC, Pinessi L, Rainero I, Sorbi S, Bruni A, Duara R, Friedland RP, Inzelberg R, Hampe W, Bujo H, Song YQ, Andersen OM, Willnow TE, Graff-Radford N, Petersen RC, Dickson D, der S, Fraser PE, Schmitt-Ulms G, Younkin S, Mayeux R, Farrer LA, St George-Hyslop P (2007) The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 39:168–177PubMedPubMedCentralCrossRef

Salta E, De Strooper B (2017) Noncoding RNAs in neurodegeneration. Nat Rev Neurosci 18:627–640PubMedCrossRef

Scheuermann JC, Boyer LA (2013) Getting to the heart of the matter: long non-coding RNAs in cardiac development and disease. EMBO J 32:1805–1816PubMedPubMedCentralCrossRef

Schmidt V, Baum K, Lao A, Rateitschak K, Schmitz Y, Teichmann A, Wiesner B, Petersen CM, Nykjaer A, Wolf J, Wolkenhauer O, Willnow TE (2012) Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease. EMBO J 31:187–200PubMedCrossRef

Schmidt V, Sporbert A, Rohe M, Reimer T, Rehm A, Andersen OM, Willnow TE (2007) SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1. J Biol Chem 282:32956–32964PubMedCrossRef

Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med

Shi C, Zhang L, Qin C (2017) Long non-coding RNAs in brain development, synaptic biology, and Alzheimer's disease. Brain Res Bull 132:160–169PubMedCrossRef

Shinohara M, Tachibana M, Kanekiyo T, Bu G (2017) Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies. J Lipid Res 58:1267–1281PubMedPubMedCentralCrossRef

Shu B, Zhang X, Du G, Fu Q, Huang L (2018) MicroRNA-107 prevents amyloid-beta-induced neurotoxicity and memory impairment in mice. Int J Mol Med 41:1665–1672PubMed

Sierksma A et al (2018) Deregulation of neuronal miRNAs induced by amyloid-beta or TAU pathology. Mol Neurodegener 13:54PubMedPubMedCentralCrossRef

Sosa LJ, Caceres A, Dupraz S, Oksdath M, Quiroga S, Lorenzo A (2017) The physiological role of the amyloid precursor protein as an adhesion molecule in the developing nervous system. J Neurochem 143:11–29PubMedCrossRef

Spadaro PA, Bredy TW (2012) Emerging role of non-coding RNA in neural plasticity, cognitive function, and neuropsychiatric disorders. Front Genet 3:132PubMedPubMedCentralCrossRef

Spreafico M, Grillo B, Rusconi F, Battaglioli E, Venturin M (2018) Multiple layers of CDK5R1 regulation in Alzheimer's disease implicate Long non-coding RNAs. Int J Mol Sci 19

Sun Q, Hao Q, Prasanth KV (2018) Nuclear Long noncoding RNAs: key regulators of gene expression. Trends Genet 34:142–157PubMedPubMedCentralCrossRef

Tateishi S, Sakuraba Y, Masuyama S, Inoue H, Yamaizumi M (2000) Dysfunction of human Rad18 results in defective postreplication repair and hypersensitivity to multiple mutagens. Proc Natl Acad Sci U S A 97:7927–7932PubMedPubMedCentralCrossRef

Thal DR, Fandrich M (2015) Protein aggregation in Alzheimer's disease: Abeta and tau and their potential roles in the pathogenesis of AD. Acta Neuropathol 129:163–165PubMedCrossRef

Tiedge H, Chen W, Brosius J (1993) Primary structure, neural-specific expression, and dendritic location of human BC200 RNA. J Neurosci 13:2382–2390PubMedPubMedCentralCrossRef

Tomita S, Kirino Y, Suzuki T (1998) Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosylation of APP in the protein secretory pathway. Identification of intracellular compartments in which APP cleavage occurs without using toxic agents that interfere with protein metabolism. J Biol Chem 273:6277–6284

Tramutola A, Di Domenico F, Barone E, Perluigi M, Butterfield DA (2016) It is all about (U)biquitin: role of altered ubiquitin-proteasome system and UCHL1 in Alzheimer disease. Oxidative Med Cell Longev 2016:2756068CrossRef

Van Gool B et al (2019) LRP1 has a predominant role in production over clearance of Abeta in a mouse model of Alzheimer's disease. Mol Neurobiol 56:7234–7245PubMedPubMedCentralCrossRef

Vardarajan BN, Zhang Y, Lee JH, Cheng R, Bohm C, Ghani M, Reitz C, Reyes-Dumeyer D, Shen Y, Rogaeva E, St George-Hyslop P, Mayeux R (2015) Coding mutations in SORL1 and Alzheimer disease. Ann Neurol 77:215–227PubMedPubMedCentralCrossRef

Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I, Nelson PT (2008) The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28:1213–1223PubMedPubMedCentralCrossRef

Wang X, Zhang M, Liu H (2019a) LncRNA17A regulates autophagy and apoptosis of SH-SY5Y cell line as an in vitro model for Alzheimer's disease. Biosci Biotechnol Biochem 83:609–621PubMedCrossRef

Wang Z, Zhao Y, Xu N, Zhang S, Wang S, Mao Y, Zhu Y, Li B, Jiang Y, Tan Y, Xie W, Yang BB, Zhang Y (2019b) NEAT1 regulates neuroglial cell mediating Abeta clearance via the epigenetic regulation of endocytosis-related genes expression. Cell Mol Life Sci 76:3005–3018PubMedPubMedCentralCrossRef

Wapinski O, Chang HY (2011) Long noncoding RNAs and human disease. Trends Cell Biol 21:354–361PubMedCrossRef

West JA, Davis CP, Sunwoo H, Simon MD, Sadreyev RI, Wang PI, Tolstorukov MY, Kingston RE (2014) The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites. Mol Cell 55:791–802PubMedPubMedCentralCrossRef

Willnow TE, Andersen OM (2013) Sorting receptor SORLA--a trafficking path to avoid Alzheimer disease. J Cell Sci 126:2751–2760PubMed

Wilusz JE (2016) Circular RNAs: unexpected outputs of many protein-coding genes. RNA Biol 14:1007–1017PubMedPubMedCentralCrossRef

Wilusz JE (2018) A 360 degrees view of circular RNAs: from biogenesis to functions. Wiley Interdiscip Rev RNA 9:e1478PubMedPubMedCentralCrossRef

Wu P, Zuo X, Deng H, Liu X, Liu L, Ji A (2013) Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases. Brain Res Bull 97:69–80PubMedCrossRef

Xu H, Sweeney D, Wang R, Thinakaran G, Lo AC, Sisodia SS, Greengard P, Gandy S (1997) Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc Natl Acad Sci U S A 94:3748–3752PubMedPubMedCentralCrossRef

Yamanaka Y, Faghihi MA, Magistri M, Alvarez-Garcia O, Lotz M, Wahlestedt C (2015) Antisense RNA controls LRP1 sense transcript expression through interaction with a chromatin-associated protein, HMGB2. Cell Rep 11:967–976PubMedPubMedCentralCrossRef

Yi J, Chen B, Yao X, Lei Y, Ou F, Huang F (2019) Upregulation of the lncRNA MEG3 improves cognitive impairment, alleviates neuronal damage, and inhibits activation of astrocytes in hippocampus tissues in Alzheimer's disease through inactivating the PI3K/Akt signaling pathway. J Cell Biochem 120:18053–18065PubMedCrossRef

Yin RH, Yu JT, Tan L (2015) The role of SORL1 in Alzheimer's disease. Mol Neurobiol 51:909–918PubMedCrossRef

Zagrebelsky M, Godecke N, Remus A, Korte M (2018) Cell type-specific effects of BDNF in modulating dendritic architecture of hippocampal neurons. Brain Struct Funct 223:3689–3709PubMedCrossRef

Zaletel I, Schwirtlich M, Perovic M, Jovanovic M, Stevanovic M, Kanazir S, Puskas N (2018) Early impairments of hippocampal neurogenesis in 5xFAD mouse model of Alzheimer's disease are associated with altered expression of SOXB transcription factors. J Alzheimers Dis 65:963–976PubMedCrossRef

Zampetaki A, Mayr M (2017) Long noncoding RNAs and angiogenesis: regulatory information for chromatin remodeling. Circulation 136:80–82PubMedCrossRef

Zeng T, Ni H, Yu Y, Zhang M, Wu M, Wang Q, Wang L, Xu S, Xu Z, Xu C, Xiong J, Jiang J, Luo Y, Wang Y, Liu H (2019) BACE1-AS prevents BACE1 mRNA degradation through the sequestration of BACE1-targeting miRNAs. J Chem Neuroanat 98:87–96PubMedCrossRef

Zhang J, Liu Z, Pei Y, Yang W, Xie C, Long S (2018) MicroRNA-322 cluster promotes tau phosphorylation via targeting brain-derived Neurotrophic factor. Neurochem Res 43:736–744PubMedCrossRef

Zhang L, Fang Y, Cheng X, Lian YJ, Xu HL (2019) Silencing of Long noncoding RNA SOX21-AS1 relieves neuronal oxidative stress injury in mice with Alzheimer's disease by Upregulating FZD3/5 via the Wnt signaling pathway. Mol Neurobiol 56:3522–3537PubMedCrossRef

Zhang M, Cai F, Zhang S, Zhang S, Song W (2014) Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer's progression in vivo. Sci Rep 4:7298PubMedPubMedCentralCrossRef

Zhang Y, Tao Y, Liao Q (2017) Long noncoding RNA: a crosslink in biological regulatory network. Brief Bioinform

Zhang Z (2016) Long non-coding RNAs in Alzheimer's disease. Curr Top Med Chem 16:511–519PubMedCrossRef

Zhao MY, Wang GQ, Wang NN, Yu QY, Liu RL, Shi WQ (2019) The long-non-coding RNA NEAT1 is a novel target for Alzheimer's disease progression via miR-124/BACE1 axis. Neurol Res 41:489–497PubMedCrossRef

Zhao ZB, Wu L, Xiong R, Wang LL, Zhang B, Wang C, Li H, Liang L, Chen SD (2014) MicroRNA-922 promotes tau phosphorylation by downregulating ubiquitin carboxy-terminal hydrolase L1 (UCHL1) expression in the pathogenesis of Alzheimer's disease. Neuroscience 275:232–237PubMedCrossRef

Zhou X, Xu J (2015) Identification of Alzheimer's disease-associated long noncoding RNAs. Neurobiol Aging 36:2925–2931PubMedCrossRef

Titel: Molecular mechanisms underlying actions of certain long noncoding RNAs in Alzheimer’s disease
verfasst von: Shamseddin Ahmadi
Mohammad Zobeiri
Steven Bradburn
Publikationsdatum: 17.03.2020
Verlag: Springer US
Erschienen in: Metabolic Brain Disease / Ausgabe 5/2020
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-020-00564-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Molecular mechanisms underlying actions of certain long noncoding RNAs in Alzheimer’s disease

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2020

Beneficial consequences of Lupeol on middle cerebral artery-induced cerebral ischemia in the rat involves Nrf2 and P38 MAPK modulation

The therapeutic potential of bilobalide on experimental autoimmune encephalomyelitis (EAE) mice

Induction of Rabies Virus Infection in Mice Brain may Up and Down Regulate Type II Interferon gamma via epigenetic modifications

Subventricular zone-derived extracellular vesicles promote functional recovery in rat model of spinal cord injury by inhibition of NLRP3 inflammasome complex formation

Translocator protein 18 kDa: a potential therapeutic biomarker for post traumatic stress disorder

Histomorphological evaluations on the frontal cortex extrapyramidal cell layer following administration of N-Acetyl cysteine in aluminum induced neurodegeneration rat model

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie